Faculty profile

Andrew Frank

ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Andrew Frank

Researcher

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
21 publications in the last five years, latest in 2025.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

321

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Alzheimer Disease Biomarkers Clinical Decision Rules Dementia Longitudinal Studies Risk Reduction Behaviour Vascular Risk Factors

Latest papers

Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.
NPJ Parkinson's disease · 2025
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson Disease.
International journal of geriatric psychiatry · 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
The journal of prevention of Alzheimer's disease · 2025

All 26 publications

Latest funding

Multinational Assessment of Risk factors and Vascular disease in Elders with dementias using Longitudinal cohort studies: The MARVEL Project
CIHR · 2024 · Principal investigator
$1,075,000

All 1 grants and awards

26 publications.

Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.

Li J, Grimes K, Saade J, Tomlinson JJ, Mestre TA, Schade S, Weber S, Dakna M, Wicke T, Lang E, Trenkwalder C, Salmaso N, Frank A, Ramsay T, Manuel D, aSCENT-PD Investigators, Mollenhauer B, Schlossmacher MG

NPJ Parkinson's disease2025

DOI: 10.1038/s41531-025-00904-5 PMID: 40268961

A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson Disease.

Rashidi-Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia MC, Freedman M, Lang A, Ramirez J, Saposnik G, McLaughlin PM, Symons S, Pollock BG, Rajji TK, Borrie M, Masellis M, Pasternak SH, Frank A, Seitz D, Ismail Z, Tang-Wai DF, Scott CJM, Dowlatshahi D, Hassan A, Munoz DG, Fornazzari L, Fischer CE, Schweizer TA

International journal of geriatric psychiatry2025

DOI: 10.1002/gps.70075 PMID: 40246706

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Macfarlane S, Grimmer T, Teo K, O'Brien TJ, Woodward M, Grunfeld J, Mander A, Brodtmann A, Brew BJ, Morris P, Short C, Kurrle S, Lai R, Bharadwaj S, Drysdale P, Sturm J, Lewis SJG, Barton D, Kalafatis C, Sharif S, Perry R, Mannering N, MacSweeney JE, Pearson S, Evans C, Krishna V, Thompson A, Munisamy M, Bhatt N, Asher A, Connell S, Lynch J, Rutgers SM, Dautzenberg PL, Prins N, Oschmann P, Frölich L, Tacik P, Peters O, Wiltfang J, Henri-Bhargava A, Smith E, Pasternak S, Frank A, Chertkow H, Ingram J, Hsiung GR, Brittain R, Tartaglia C, Cohen S, Villa LM, Gordon E, Jubault T, Guizard N, Tucker A, Kaufmann WE, Jin K, Chezem WR, Missling CU, Sabbagh MN

The journal of prevention of Alzheimer's disease2025

DOI: 10.1016/j.tjpad.2024.100016 PMID: 39800452

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L

The journal of prevention of Alzheimer's disease202537 citations

DOI: 10.1016/j.tjpad.2025.100068

Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases

Sanchez E, Coughlan GT, Wilkinson T, Ramirez J, Mirza SS, Baril A-A, Dilliott AA, Frank A, Lang AE, Hassan A

Neurology202529 citations

DOI: 10.1212/wnl.0000000000213438

History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment.

Khoury MA, Churchill NW, Di Battista A, Graham SJ, Symons S, Troyer AK, Roberts A, Kumar S, Tan B, Arnott SR, Ramirez J, Tartaglia MC, Borrie M, Pollock B, Rajji TK, Pasternak SH, Frank A, Tang-Wai DF, Scott CJM, Haddad SMH, Nanayakkara N, Orange JB, Peltsch A, Fischer CE, Munoz DG, Schweizer TA

Journal of neurology2024

DOI: 10.1007/s00415-024-12369-2 PMID: 38717612

Development and Initial Testing of an Artificial Intelligence-Based Virtual Reality Companion for People Living with Dementia in Long-Term Care.

Sheehy L, Bouchard S, Kakkar A, El Hakim R, Lhoest J, Frank A

Journal of clinical medicine2024Senior author

DOI: 10.3390/jcm13185574 PMID: 39337060

Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

Sanchez E, Wilkinson T, Coughlan G, Mirza S, Baril A, Ramirez J, Binns MA, Black SE, Borrie M, Dilliott AA

Alzheimer's and Dementia202464 citations

DOI: 10.1002/alz.13560

Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases

Andriuta D, Ottoy J, Ruthirakuhan M, Feliciano G, Dilliott AA, Hegele RA, Gao F, McLaughlin PM, Rabin JS, Alexander MW

Alzheimer's and Dementia202417 citations

DOI: 10.1002/alz.14081

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Rashidi‐Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia MC, Freedman M, Lang A, Steeves TDL, Swartz RH, Saposnik G

International Journal of Geriatric Psychiatry202410 citations

DOI: 10.1002/gps.6074

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Alzheimer Disease Dear Professor Frank, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Multinational Assessment of Risk factors and Vascular disease in Elders with dementias using Longitudinal cohort studies: The MARVEL Project" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Andrew Frank

Research

Latest papers

Latest funding

Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.

A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson Disease.

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases

History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment.

Development and Initial Testing of an Artificial Intelligence-Based Virtual Reality Companion for People Living with Dementia in Long-Term Care.

Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Multinational Assessment of Risk factors and Vascular disease in Elders with dementias using Longitudinal cohort studies: The MARVEL Project

Frequent collaborators

Mario Masellis

Sanjeev Kumar

Michael Borrie

Elizabeth Finger

Gustavo Saposnik

Dar Dowlatshahi

Demetrios Sahlas

Dallas Seitz

David Grimes

John Turnbull

Connie Marras

Robert Bartha

Ekaterina Rogaeva

Anthony Lang

Stephen Pasternak

Angela Roberts

Zahinoor Ismail

Manuel Montero Odasso

Michael Borrie

Marvin Chum

Maged Goubran

Walter Swardfager

Brian Levine

Wendy Lou

Matthew Bromwich

Howard Chertkow

Amanpreet Badhwar

Julie Ottoy